RelB/p50 regulates CCL19 production, but fails to promote human DC maturation

18Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

DC, when fully matured are the APC best able to activate naïve T cells. Recently, we demonstrated using adenoviruses overexpressing IκBα and proteosome inhibitors that NF-κB is involved in DC activation, but the role of the individual subunits is still not clear. We investigated the role of the NF-κB subunits RelB and p50 in human DC activation using adenoviral vectors expressing RelB or p50. Nuclear RelB, in the form of RelB/p50, was active only in DC infected with both viruses, this induced the production of the soluble homeostatic chemokine CCL19, but not other homeostatic chemokines, particularly in LPS-matured DC. However, RelB/p50 did not affect the expression of costimulatory and antigen-presenting molecules, and increased the allogeneic mixed lymphocyte reaction only in LPS-matured DC. This enhanced mixed lymphocyte reaction is most likely due to enhanced CCL19 production, which sustains the interaction between mature DC and naïve T cells. In conclusion, we demonstrated that RelB/p50 was active only in DC expressing both RelB and p50, and induced CCL19 production, but not DC maturation. © 2009 Wiley-VCH Verlag GmbH & Co. KGaA.

Cite

CITATION STYLE

APA

Gasparini, C., Foxwell, B. M. J., & Feldmann, M. (2009). RelB/p50 regulates CCL19 production, but fails to promote human DC maturation. European Journal of Immunology, 39(8), 2215–2223. https://doi.org/10.1002/eji.200939209

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free